Metropolis Healthcare shares hit 52-week high on strong Q4 earnings

Metropolis Healthcare shares surged on Wednesday, May 22, gaining as much as 6.3 per cent to reach a 52-week high of Rs 2,023.45 on the National Stock Exchange (NSE).

The positive momentum in the stock price was driven by the diagnostics company’s impressive quarterly earnings, which largely met analysts’ expectations.


Metropolis Healthcare reported an 8 percent year-on-year increase in consolidated net profit, reaching Rs 36 crore for the March quarter.

The company’s revenue also witnessed robust growth, rising 11 percent from the year-ago quarter to Rs 313 crore, up from Rs 282 crore.

As of 10:55 am, the shares were trading 5.58% higher at Rs 2,008.95 on the stock exchange.

Key highlights from Metropolis Healthcare’s Q4 results include:

– The reported EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortization) for Q4 grew 15%, in line with estimates.
– Core revenues for Q4 were up 15% year-on-year, led by a 7.3% growth in core patient volumes.
– The contribution from non-core segments remained stable at 15% of total revenues, quarter-on-quarter.